Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
Ikena Oncology
Ikena Oncology
Vanderbilt-Ingram Cancer Center
University of Pittsburgh
M.D. Anderson Cancer Center
SWOG Cancer Research Network
National Cancer Institute (NCI)
Herlev Hospital